FDA Concluded Investigation into Infant Formula Outbreak
The investigation identified two formula brands linked to the hospitalization of 50 infants.
Updated on Oct. 5, 2026 in Babies
Live Poll
Should federal regulators mandate stricter botulism testing for all infant formula manufacturers?
The FDA has finished its inquiry into a botulism outbreak tied to infant formula that resulted in the hospitalization of 50 babies. Investigators traced the source to milk ingredients from 22 separate dairies.
Why it matters
The investigation highlights ongoing risks in the infant formula supply chain, as there is currently no federal mandate requiring powdered formula to be tested for botulism.
The FDA investigation identified 22 dairies as the source of contaminated milk ingredients. Botulism reports linked to infant formula have appeared in agency databases for over 20 years.
The players
FDA
The Food and Drug Administration is the federal agency responsible for protecting public health by ensuring the safety of food and medical products.
ByHeart
ByHeart is an infant formula manufacturer that was identified as one of the brands involved in the recent outbreak.
Nara
Nara is an infant formula brand that was implicated in the botulism investigation.
The details
ByHeart and Nara were the two brands implicated in the outbreak, with ByHeart noting it lacked visibility into specific farms selected by its suppliers. Manufacturers are now moving to change milk suppliers and implement stricter internal testing protocols.
Timeline
Three years ago, the first infection in the outbreak occurred.
In 2023, the FDA issued a warning regarding botulism in infant formula.
Culture Shift
This event reflects a growing demand for increased supply chain transparency in the food industry. It follows a pattern set by the proposed federal mandate for infant formula botulism testing, which seeks to formalize safety standards that are currently voluntary.
Parents may see changes in product availability as brands switch suppliers and update their manufacturing procedures. Families are encouraged to stay informed about product safety announcements and new quality control measures as they are implemented.
The takeaway
Parents should continue to monitor health and nutrition alerts for any updates regarding infant formula safety. Ensuring that manufacturers implement robust testing protocols remains a critical step for preventing future contamination incidents.
What happens next
Congress is currently considering a bill that would establish a mandatory testing requirement for botulism across the infant formula industry.
Further reading
For more information on infant nutrition safety, visit the Babies section.
Source note: This article includes information reported by The National Desk.
Live Poll
Should federal regulators mandate stricter botulism testing for all infant formula manufacturers?
